332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I

Analyzing the Rates of Heavy Menstrual Bleeding By Anticoagulant Type in Menstruating Individuals: A Large National Database Study

Anticoagulation Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis

Anticoagulation and Major Bleeding or Recurrent Thrombosis in Patients with Isolated Cancer-Associated Splanchnic Vein Thrombosis: A Multi-Center Cohort Study

Budd-Chiari Syndrome: Pathogenetic Factors and Completeness of Screening for Paroxysmal Nocturnal Hemoglobinuria

Characterizing Diagnostic Investigations for Suspected Pulmonary Embolism in Postpartum Individuals

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients Using Implanted Central Venous Access Devices

First in-Human Study with Okl-1111, a Novel Small Molecule Universal Anticoagulant and Platelet Inhibitor Reversal Agent

Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation

Risk of Pregnancy-Associated Venous Thromboembolism in Sickle Cell Trait

Rivaroxaban in Paediatric Venous Malformations: Preliminary Data from a Retrospective Single-Center Study

To be or Not to be? Exploring the Monitoring of Direct Oral Anticoagulants (DOACs) in Routine Clinical Practice

Venous Thromboembolism Incidence in Patients with Cancer and Factor XI Deficiency